Home » Tenders » Americas » USA » Tender 139675609

Hazardous Drug Sample Analysis Tender in USA - 139675609

The ITY-RESULT _NGCONTENT-NG-C92264979="" _NGHOST-NG-C893956049="" CLASS="NG-STAR-INSERTED" HAZARDOUS DRUG SAMPLE ANALYSIS has issued a Tender notice for the procurement of a Hazardous Drug Sample Analysis in the USA. This Tender notice was published on 17 Apr 2026 and is scheduled to close on 24 Apr 2026, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 139675609, while the tender notice number is HT942726QE008 and Registering on the platform.

Procurement Summary

Country: USA

Summary: Hazardous Drug Sample Analysis

Deadline: 24 Apr 2026

Posting Date: 17 Apr 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 139675609

Document Ref. No.: HT942726QE008

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Tender Details

As part of the DCPH-A mission, the Lab Sciences (LS) Directorate requires the analysis of wipe/swab samples for the presence of hazardous drugs in support of pharmacies and Military Treatment Facilities (MTFs) within the Department of War (DoW). This analysis is mandated for the MTFs using Chemotherapy drugs to ensure their cleaning procedures are effective to ensure safety of the MTF staff and to avoid cross-contamination. The directives that mandate this semi-annual testing requirement are United Stated Pharmacopiea (USP) 800: Handling Hazardous Drugs and Technical Bulletin-Medical (TB-MED) 515: Occupational Health and Indutrial Hygiene Guidance for the Management, Use and Disposal of Hazardous Drugs. There is no acceptable level of occupational exposure to Hazardous Drugs. The LS Directorate of the DCPH-A is the only government laboratory to perform this hazardous drugs analysis as required. While LS does have the analytical capability to perform hazardous drugs analyses, as a sole source for this effort, there is a need to have back-up laboratory capability for instances of instrument down-time or over-capacity situations.
Objectives for this Requirement are as follows:
The Contractor shall perform analysis on wipe/swab samples provided by the Government for Hazardous Drugs contamination.
The Contractor shall perform the sample analysis within the stated turnaround time (TAT) identified in the Outsource Document and identified in the PWS.
The Contractor shall provide Quality wipe/swab analysis for various hazardous drugs as identified in this PWS in accordance with an accredited methodology.
The Contractor shall dispose of unused samples as prescribed by their quality manual/Standing Operating Procedures and return Government shipping containers.
The Contractor shall supply sampling media upon request.
The Contractor shall pay liquidated damages for late or deficient reporting as detailed in Section 5.of the PWS.
QUESTIONS are due by 20 A...
Notice ID: ht942726qe008

Department/Ind. Agency: dept of defense

Sub-tier: defense health agency (dha)

Office: defense health agency

Product Service Code: q301 - reference laboratory testing

NAICS Code: 541380 - Testing Laboratories and Services

Inactive Dates: may 09, 2026

Inactive Policy: 15 days after date offers due

Documents

Browse More

All Tenders From Americas

Procurement Documents for USA

Access a comprehensive library of standard procurement documents specific to USA. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in USA

Explore Procurement Documents for USA

Want To Bid in This Tender?

Get Local Agent Support in USA and 60 More Countries.

View All The Services

View Tenders By